Meda Pharma Gmbh & Co. Kg

Peter Jurgen Cnota

Istvan Szelenyi

Joachim Maus

Horst Kastrup

Artur Bauhofer

Torsten Hoffmann

Joachim Goede

Mario Weingart

Beatrix Fyrnys

Ursula Petzold

Ullrich Munzel

Kastrup Horst

Bauhofer Artur

The invention relates to novel combinations based on anticholinergics, &#x3b2;-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.

Combination of anticholinergics, &#x3b2;2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases

Pharmaceutical compositions comprising an anticholinergic and at least one leukotriene inhibitor for treatment of respiratory diseases, including allergic rhinitis, bronchial asthma, COPD and common cold, and methods of treatment.

Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases

The present invention describes a combination of an anticholinergic, such as R,R-glycopyrrolate, and a &#x3b2; mimetic, such as tormoterol, for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma.

Combination of anticholineric and &#x3b2; mimetics for the treatment of respiratory diseases

The subject of the present invention is to provide a combination of two centrally acting analgesics, flupirtine and tramadol, or their respective pharmaceutically acceptable salts for the treament of pain.

Combination of flupirtine and tramadol

Growing community of inventors

Bad Homburg, Germany

Peter Jurgen Cnota